AsclepiX Therapeutics
Jill Vazzano Tierney has a background in finance and has held various roles in different companies such as AsclepiX Therapeutics, Aerie Pharmaceuticals, and TMG Health. Currently serving as the Managing Director Finance and Board Observer at Holland Foundation For Sight Restoration, Jill provides financial management and services to assist the Board of Directors. With experience in financial planning, analysis, and operations, Jill has honed their skills in budgeting, forecasting, and project management. A graduate of Saint Joseph's University with a B.S in Business and Economics, with a major in Finance, Jill's expertise in the financial sector has been showcased throughout their career.
This person is not in any offices
AsclepiX Therapeutics
1 followers
AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maintaining homeostasis, the fundamental principle of biology to seek and maintain a condition of equilibrium or stability.